119 related articles for article (PubMed ID: 22294728)
1. Identification of TRIB1 R107L gain-of-function mutation in human acute megakaryocytic leukemia.
Yokoyama T; Toki T; Aoki Y; Kanezaki R; Park MJ; Kanno Y; Takahara T; Yamazaki Y; Ito E; Hayashi Y; Nakamura T
Blood; 2012 Mar; 119(11):2608-11. PubMed ID: 22294728
[TBL] [Abstract][Full Text] [Related]
2. The role of Trib1 in myeloid leukaemogenesis and differentiation.
Nakamura T
Biochem Soc Trans; 2015 Oct; 43(5):1104-7. PubMed ID: 26517931
[TBL] [Abstract][Full Text] [Related]
3. Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis.
Yokoyama T; Kanno Y; Yamazaki Y; Takahara T; Miyata S; Nakamura T
Blood; 2010 Oct; 116(15):2768-75. PubMed ID: 20610816
[TBL] [Abstract][Full Text] [Related]
4. COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1.
Yoshida A; Kato JY; Nakamae I; Yoneda-Kato N
Blood; 2013 Sep; 122(10):1750-60. PubMed ID: 23884858
[TBL] [Abstract][Full Text] [Related]
5. Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.
Yoshino S; Yokoyama T; Sunami Y; Takahara T; Nakamura A; Yamazaki Y; Tsutsumi S; Aburatani H; Nakamura T
Blood; 2021 Jan; 137(1):75-88. PubMed ID: 32730594
[TBL] [Abstract][Full Text] [Related]
6. Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia.
Dedhia PH; Keeshan K; Uljon S; Xu L; Vega ME; Shestova O; Zaks-Zilberman M; Romany C; Blacklow SC; Pear WS
Blood; 2010 Aug; 116(8):1321-8. PubMed ID: 20410507
[TBL] [Abstract][Full Text] [Related]
7. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.
Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC
Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356
[TBL] [Abstract][Full Text] [Related]
8. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages.
Satoh T; Kidoya H; Naito H; Yamamoto M; Takemura N; Nakagawa K; Yoshioka Y; Morii E; Takakura N; Takeuchi O; Akira S
Nature; 2013 Mar; 495(7442):524-8. PubMed ID: 23515163
[TBL] [Abstract][Full Text] [Related]
9. Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome.
Yoshino S; Tanaka M; Sunami Y; Takahara T; Yamazaki Y; Homme M; Niibori-Nambu A; Osato M; Minami T; Ishihara K; Nakamura T
Leukemia; 2022 Feb; 36(2):558-561. PubMed ID: 34381180
[No Abstract] [Full Text] [Related]
10. Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.
Salomé M; Hopcroft L; Keeshan K
Exp Hematol; 2018 Oct; 66():63-78.e13. PubMed ID: 30031847
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanism of CCAAT-Enhancer Binding Protein Recruitment by the TRIB1 Pseudokinase.
Murphy JM; Nakatani Y; Jamieson SA; Dai W; Lucet IS; Mace PD
Structure; 2015 Nov; 23(11):2111-21. PubMed ID: 26455797
[TBL] [Abstract][Full Text] [Related]
12. Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia.
Keeshan K; He Y; Wouters BJ; Shestova O; Xu L; Sai H; Rodriguez CG; Maillard I; Tobias JW; Valk P; Carroll M; Aster JC; Delwel R; Pear WS
Cancer Cell; 2006 Nov; 10(5):401-11. PubMed ID: 17097562
[TBL] [Abstract][Full Text] [Related]
13. [The molecular mechanism of leukemogenesis in Down syndrome-related acute megakaryocytic leukemia].
Ito E; Toki T
Nihon Rinsho; 2007 Jan; 65 Suppl 1():136-40. PubMed ID: 17476742
[No Abstract] [Full Text] [Related]
14. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis.
Klusmann JH; Godinho FJ; Heitmann K; Maroz A; Koch ML; Reinhardt D; Orkin SH; Li Z
Genes Dev; 2010 Aug; 24(15):1659-72. PubMed ID: 20679399
[TBL] [Abstract][Full Text] [Related]
15. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
[TBL] [Abstract][Full Text] [Related]
16. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
[TBL] [Abstract][Full Text] [Related]
17. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
[No Abstract] [Full Text] [Related]
18. Trib1 Is Overexpressed in Systemic Lupus Erythematosus, While It Regulates Immunoglobulin Production in Murine B Cells.
Simoni L; Delgado V; Ruer-Laventie J; Bouis D; Soley A; Heyer V; Robert I; Gies V; Martin T; Korganow AS; Reina-San-Martin B; Soulas-Sprauel P
Front Immunol; 2018; 9():373. PubMed ID: 29599769
[TBL] [Abstract][Full Text] [Related]
19. The complex relationship of Tribbles pseudokinase 1, PML/RARA and C/EBPα in leukemia: two possible couples but not a trio.
Velasco G
Haematologica; 2016 Oct; 101(10):1129-1130. PubMed ID: 27694499
[No Abstract] [Full Text] [Related]
20. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
